DNA Simple, DNA kits for research studies that pay consumers $50, was started by Olivier Noel in 2015. As of November 2023, DNA Simple net worth is $1.3 million. And they’re pulling in a whopping $5 million in annual revenue.
In November 2017, they appeared on season 9 of Shark Tank USA. And made a deal with Mark Cuban, for $200,000 for 15% of equity. The final valuation was $ 1.3 million, down from the founder’s initial estimate of $800,000.
DNASimple is still in business. The company has raised over $5 million in funding and has matched over 500 spit donors to research studies. To buy their DNA kits visit their official website.
DNA Simple Net Worth
|Net worth||$1.3 million (2023)|
|Annual Sales Revenue||$5 million (2023)|
|Profits||Not Publicly Available|
|Lifetime sales||Not Publicly Available|
|Investor||$100,000 for 12.5% equity|
|Founder||$200,000 for 15% equity|
|Employees||Not Publicly Available|
DNA Simple Net Worth Timeline
|Net Worth 2023||$1.3 million|
|Net Worth 2022||$1.3 million|
|Net worth valuation 2017 after appearing on Shark Tank||$800,000|
|Net worth valuation 2017 before appearing on Shark Tank||$1.3 million|
DNA Simple Pitch on Shark Tank
|Company name||DNA Simple|
|Product||DNA kits for research studies that pay consumers $50|
|Episode||Season 09 Episode 10|
|Asked for||$100,000 for 12.5% equity|
|Final deal||$200,000 for 15% equity|
Don’t miss these product from Season 09
DNA Simple Founder
DNA Simple was founded by Olivier Noel in 2015. He is a medical doctor and a PhD in molecular biology, with over 15 years of experience in genetics and genomics research. DNA Simple’s founder, Olivier Noel, has a net worth of $1.3 million as of 2023.
|2017||Appeared on Shark Tank season 09 and Mark Cuban invested $200,000 for 15% equity|
|2019||Expanded to international markets|
|2020||Launched new DNA testing products|
From their beginnings on Shark Tank to their current status as a thriving business, they have proven that with the right idea and execution, anything is possible. We can’t wait to see the future for DNA Simple and its continued success.